Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 06, 2022 07:30 ET | Source: BiondVax Pharmaceuticals Ltd.

Professor Dr. Matthias Dobbelstein joins BiondVax’s Scientific Advisory Board

Jerusalem, Dec. 06, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on developing, manufacturing and commercializing...